Pramod Sarpotdar

Title: Pramod Sarpotdar: Innovator in Ophthalmic Formulations

Introduction

Pramod Sarpotdar is a notable inventor based in Roseville, CA (US). He has made significant contributions to the field of ophthalmology, particularly through his innovative formulations of methotrexate. With a total of 2 patents, Sarpotdar's work is paving the way for advancements in ocular treatments.

Latest Patents

Sarpotdar's latest patents focus on ophthalmic formulations of methotrexate. These formulations are designed for ocular administration, including intravitreal administration. They are intended for treating conditions such as proliferative vitreoretinopathy (PVR), intraocular lymphoma (PVRL), and intraocular inflammation. His research aims to improve the efficacy of treatments for these serious eye conditions.

Career Highlights

Pramod Sarpotdar is currently associated with Aldeyra Therapeutics, Inc., where he continues to develop innovative solutions in the field of ophthalmology. His expertise and dedication to research have positioned him as a key figure in the development of new therapeutic approaches.

Collaborations

Sarpotdar has collaborated with esteemed colleagues such as Dean Eliott and Stephen Gitu Machatha. These partnerships enhance the research and development efforts at Aldeyra Therapeutics, Inc., contributing to the advancement of ocular therapies.

Conclusion

Pramod Sarpotdar's contributions to ophthalmic formulations demonstrate his commitment to improving patient outcomes in eye care. His innovative work continues to inspire advancements in the treatment of ocular diseases.